Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s EBIT?
- Krystal Biotech, Inc. (KRYS) reported EBIT of $53.69M in Q1 2026.
- How has Krystal Biotech, Inc.'s EBIT changed year-over-year?
- Krystal Biotech, Inc.'s EBIT increased by 48.1% year-over-year, from $36.25M to $53.69M.
- What is the long-term trend for Krystal Biotech, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s EBIT has grown at a 24.0% compound annual growth rate (CAGR), from -$68.27M to $161.2M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Krystal Biotech, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude